Early Neurological Deterioration After Intravenous Thrombolysis: Still No End in Sight in the Quest for Understanding END

Stroke. 2020 Sep;51(9):2615-2617. doi: 10.1161/STROKEAHA.120.030982. Epub 2020 Aug 19.

Author

Panayiotis D Mitsias^{1

2

3}

Affiliations

¹ Department of Neurology, School of Medicine, University of Crete, Heraklion, Greece (P.D.M.).
² Comprehensive Stroke Center and Department of Neurology, Henry Ford Hospital, Detroit, MI (P.D.M.).
³ School of Medicine, Wayne State University, Detroit, MI (P.D.M.).

PMID: 32811379
DOI: 10.1161/STROKEAHA.120.030982

No abstract available

Keywords: Editorials; blood pressure; cerebral hemorrhage; ischemic stroke; mortality; reperfusion; tissue -type plasminogen activator.

Publication types

Editorial
Comment

MeSH terms

Incidence
Registries
Thrombolytic Therapy*
Tissue Plasminogen Activator* / adverse effects

Substances

Tissue Plasminogen Activator